arrow
Q

Qiuling Wu

tongji medical college
H指数:24
被引数:2,090

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modified azacitidine plus cytarabine versus traditional cytarabine in patients with newly diagnosed acute myeloid leukaemia: a retrospective and propensity score matched analysis

改良型氮杂胞苷联合阿糖胞苷与传统阿糖胞苷在 newly diagnosed acute myeloid leukaemia 患者中的比较:一项回顾性研究和倾向性评分匹配分析

2026-08-260
OA
The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia

交替使用减量布林妥单抗和hyper-CVAD作为新诊断成人B细胞急性淋巴细胞白血病患者巩固治疗方案的联合应用

2026-08-140
PRE
Corrigendum to “Elucidating the distinctive regulatory effects and mechanisms of active compounds in Salvia miltiorrhiza Bunge via network pharmacology: Unveiling their roles in the modulation of platelet activation and thrombus formation” [Toxicology and Applied Pharmacology volume 484, March 2024, 116871]

勘误:关于“通过网络药理学阐明丹参(Salvia miltiorrhiza Bunge)中活性化合物的独特调控效应和机制:揭示其在血小板活化与血栓形成调控中的作用” [毒理学与应用药理学,卷484,2024年3月,116871]

2025-12-040
OAAI
Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

单剂量与分次剂量Mecapegfilgrastim联合依托泊苷用于自体外周血干细胞动员的疗效与安全性:一项前瞻性、随机临床试验

BLOOD
IF23.1
2024-11-050
PRE